About this trial
This study is designed to evaluate the use of Emdogain® MI in a procedure where a significant portion of the lining of the sulcus is removed by curettage (similar to the traditional clinical procedure described as "gingival curettage") to the point of tissue mobility. This will be designated as a "non-incised minimally invasive flap access procedure". A videoscope will be utilized to assist with the requirement to adequately visualize and debride the root surface. This research project will define the approach used as a "non-incised minimally invasive flap access" approach and will be a modification of recognized minimally invasive techniques. This modification will be made by Dr. Harrel who first describe the minimally invasive periodontal approach and defined minimally invasive periodontal procedures in 1995.
Eligibility criteria
Qualifiers
Generalized gum disease with isolated pocket depths of 5 mm to less than 7 mm on bicuspid and cuspid teeth.
At least 2 mm of attachment loss.
Need to have two similar teeth meeting the criteria for isolated pockets on two other quadrants of the mouth.
Need to be between 30 and 75 years of age.
Disqualifiers
You are pregnant.
You are breast feeding.
Received gum treatment in the last 6 months.
Smoke more than ten cigarettes per day.
Trial design
Treatments tested in this trial
- Minimally invasive periodontal therapy with use of Emdogain
- Minimally invasive periodontal therapy without the use of Emdogain
Treatment groups
Sponsors and collaborators
Texas A&M University
Lead sponsor
Institut Straumann AG
Collaborator